BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a significant increase in short interest in October. As of October 15th, there was short interest totaling 14,200 shares, an increase of 77.5% from the September 30th total of 8,000 shares. Based on an average daily trading volume, of 4,400 shares, the short-interest ratio is currently 3.2 days. Currently, 0.0% of the shares of the stock are short sold. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,400 shares, the short-interest ratio is currently 3.2 days.

BioNxt Solutions Trading Down 5.6%

OTCMKTS BNXTF opened at $0.58 on Friday. BioNxt Solutions has a 1-year low of $0.16 and a 1-year high of $0.80. The company has a 50 day moving average of $0.64 and a 200-day moving average of $0.50. The company has a market cap of $67.51 million, a price-to-earnings ratio of -14.58 and a beta of 0.80.

BioNxt Solutions (OTCMKTS:BNXTF) last released its quarterly earnings results on Thursday, August 28th. The company reported ($0.01) earnings per share for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.